Irsicaixa

Tamaño actual: 100%

idioma:

CONTENIDO

Publicaciones

Año

Mutant spectra in virus behavior
Celia Perales, Ramón Lorenzo-Redondo, Cecilio López-Galíndez, Miguel Angel Martínez, Esteban Domingo
10.2217/FVL.10.61 © 2010 Future Medicine Ltd
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study
Llibre JM, Buzón MJ, Massanella M, Esteve A, Dahl V, Puertas MC, Domingo P, Gatell JM, Larrouse M, Gutierrez M, Palmer S, Stevenson M, Blanco J, Martinez-Picado J, Clotet B.
Antivir Ther. 2012;17(2):355-64. doi: 10.3851/IMP1917. Epub 2011 Sep 28.
Rationally Designed Interfacial Peptides Are Efficient In Vitro Inhibitors of HIV-1 Capsid Assembly with Antiviral Activity
Miguel Angel, Maria
doi:10.1371/journal.pone.0023877
RNA Interference as a Tool for Exploring HIV-1 Robustness
Maria Nevot, Gloria Martrus, Bonaventura Clotet and Miguel Angel Martínez
doi:10.1016/j.jmb.2011.08.035
A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity
Sonsoles Sánchez-Palomino^{a, 1}, Marta Massanella^{b, 1}, Jorge Carrillo^b, Ana García^a, Felipe García^a, Nuria González^c, Alberto Merino^a, José Alcamí^c, Margarita Bofill^{b, d}, Eloísa Yuste^a, Josep M. Gatell^a, Bonaventura Clotet^b, Julià Blanco^b

^a Infectious Diseases Unit-HIVACAT, Hospital Clínic, Barcelona, Spain
^b Fundació irsiCaixa-HIVACAT, Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
^c AIDS Immunopathogenesis Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
^d Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

¹These authors contributed equally to this work.
Vaccine. 2011 Jul 18;29(32):5250-9. doi: 10.1016/j.vaccine.2011.05.016. Epub 2011 May 24

IrsiCaixa

Destacados

Publicaciones

Mutant spectra in virus behavior

10.2217/FVL.10.61 © 2010 Future Medicine Ltd

Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study

Antivir Ther. 2012;17(2):355-64. doi: 10.3851/IMP1917. Epub 2011 Sep 28.

Rationally Designed Interfacial Peptides Are Efficient In Vitro Inhibitors of HIV-1 Capsid Assembly with Antiviral Activity

doi:10.1371/journal.pone.0023877

RNA Interference as a Tool for Exploring HIV-1 Robustness

doi:10.1016/j.jmb.2011.08.035

A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity

Vaccine. 2011 Jul 18;29(32):5250-9. doi: 10.1016/j.vaccine.2011.05.016. Epub 2011 May 24